BBIO logo

BridgeBio Pharma, Inc. (BBIO) Cash From Financing

Annual CFF:

$748.46M+$296.92M(+65.76%)
December 31, 2024

Summary

  • As of today, BBIO annual cash from financing is $748.46 million, with the most recent change of +$296.92 million (+65.76%) on December 31, 2024.
  • During the last 3 years, BBIO annual cash from financing has risen by +$12.01 million (+1.63%).
  • BBIO annual cash from financing is now at all-time high.

Performance

1-Year Change

+65.76%

3-Year Change

+1.63%

5-Year Change

+87.68%

15-Year Change

+562.45%

BBIO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

98.33%
BBIO annual cash from financing is higher than 98.33% of companies in Healthcare sector

Range

All-Time High

$748.46M
BBIO annual cash from financing is currently at an all-time high

3-Year Low

-$13.13M
BBIO annual cash from financing is currently +5798.62% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BBIO next annual earnings announcement has not yet been scheduled

OtherBBIOcash flow metrics

Annual CFI

$60.78M
BBIO annual cash from investing is $60.78 million

Annual CFO

-$520.73M
BBIO annual cash from operations is -$520.73 million

Annual FCF

-$529.63M
BBIO annual free cash flow is -$529.63 million

Annual CAPEX

$8.91M
BBIO annual capital expenditures is $8.91 million

Quarterly CFF:

$302.04M+$241.71M(+400.66%)
June 30, 2025

Summary

  • As of today, BBIO quarterly cash from financing is $302.04 million, with the most recent change of +$241.71 million (+400.66%) on June 30, 2025.
  • Over the past year, BBIO quarterly cash from financing has increased by +$307.77 million (+5372.14%).
  • BBIO quarterly cash from financing is now -44.87% below its all-time high of $547.91 million, reached on March 31, 2021.

Performance

3-Month Change

+400.66%

1-Year Change

+5372.14%

3-Year Change

+1552.4%

5-Year Change

+42864.58%

BBIO Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

99.01%
BBIO quarterly cash from financing is higher than 99.01% of companies in Healthcare sector

Range

All-Time High

$547.91M
BBIO quarterly cash from financing is currently -44.87% below its historical high of $547.91 million

3-Year Low

-$5.73M
BBIO quarterly cash from financing is currently +5372.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBIO previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
BBIO next earnings announcement is scheduled for Oct 29, 2025

OtherBBIOcash flow metrics

Quarterly CFI

-$13.00M
BBIO quarterly cash from investing is -$13.00 million

Quarterly CFO

-$80.68M
BBIO quarterly cash from operations is -$80.68 million

Quarterly FCF

-$85.78M
BBIO quarterly free cash flow is -$85.78 million

Quarterly CAPEX

$5.09M
BBIO quarterly capital expenditures is $5.09 million

TTM CFF:

$837.01M+$307.77M(+58.15%)
June 30, 2025

Summary

  • As of today, BBIO TTM cash from financing is $837.01 million, with the most recent change of +$307.77 million (+58.15%) on June 30, 2025.
  • Over the past year, BBIO TTM cash from financing has increased by +$260.67 million (+45.23%).
  • BBIO TTM cash from financing is now -1.56% below its all-time high of $850.29 million, reached on June 30, 2020.

Performance

3-Month Change

+58.15%

1-Year Change

+45.23%

3-Year Change

+395.36%

5-Year Change

+72.38%

BBIO TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

99.46%
BBIO TTM cash from financing is higher than 99.46% of companies in Healthcare sector

Range

All-Time High

$850.29M
BBIO TTM cash from financing is currently -1.56% below its historical high of $850.29 million

3-Year Low

-$13.13M
BBIO TTM cash from financing is currently +6472.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBIO previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
BBIO next earnings announcement is scheduled for Oct 29, 2025

OtherBBIOcash flow metrics

TTM CFI

$20.39M
BBIO TTM cash from investing is $20.39 million

TTM CFO

-$655.81M
BBIO TTM cash from operations is -$655.81 million

TTM FCF

-$667.47M
BBIO TTM free cash flow is -$667.47 million

TTM CAPEX

$11.66M
BBIO TTM capital expenditures is $11.66 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BBIO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+65.8%+5372.1%+45.2%
3Y3 Years+1.6%+1552.4%+395.4%
5Y5 Years+87.7%+10000.0%+72.4%

BBIO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+5798.6%-36.3%+5372.1%at high+6472.8%
5Y5-Yearat high+5798.6%-44.9%+323.0%at high+6472.8%
All-TimeAll-Timeat high+5798.6%-44.9%+323.0%-1.6%+6472.8%

BBIO Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$302.04M(+400.7%)
$837.01M(+58.2%)
Mar 2025
-
$60.33M(-87.3%)
$529.24M(-29.3%)
Dec 2024
$748.46M(+65.8%)
$473.93M(>+9900.0%)
$748.46M(+177.2%)
Sep 2024
-
$707.00K(+112.3%)
$270.00M(-53.2%)
Jun 2024
-
-$5.73M(-102.0%)
$576.34M(-0.8%)
Mar 2024
-
$279.55M(+6280.6%)
$580.83M(+28.6%)
Dec 2023
$451.54M(+3537.9%)
-$4.52M(-101.5%)
$451.54M(-2.4%)
Sep 2023
-
$307.04M(>+9900.0%)
$462.44M(+194.8%)
Jun 2023
-
-$1.23M(-100.8%)
$156.84M(+14.3%)
Mar 2023
-
$150.25M(+2256.1%)
$137.28M(+1145.2%)
Dec 2022
-$13.13M(-101.8%)
$6.38M(+341.3%)
-$13.13M(-104.3%)
Sep 2022
-
$1.45M(+106.9%)
$305.87M(+81.0%)
Jun 2022
-
-$20.80M(>-9900.0%)
$168.97M(-10.3%)
Mar 2022
-
-$160.00K(-100.0%)
$188.37M(-74.4%)
Dec 2021
$736.45M
$325.38M(+340.2%)
$736.45M(+77.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$135.46M(-9638.0%)
$415.60M(-25.0%)
Jun 2021
-
-$1.39M(-100.3%)
$553.83M(-0.4%)
Mar 2021
-
$547.91M(>+9900.0%)
$555.93M(+24.3%)
Dec 2020
$447.19M(+12.1%)
$4.53M(+62.9%)
$447.19M(-7.9%)
Sep 2020
-
$2.78M(+295.7%)
$485.56M(-42.9%)
Jun 2020
-
$703.00K(-99.8%)
$850.29M(+1.3%)
Mar 2020
-
$439.17M(+923.6%)
$839.62M(+110.5%)
Dec 2019
$398.79M(-20.5%)
$42.90M(-88.3%)
$398.79M(-36.7%)
Sep 2019
-
$367.51M(+3786.5%)
$630.06M(+141.6%)
Jun 2019
-
-$9.97M(-503.8%)
$260.83M(-46.1%)
Mar 2019
-
-$1.65M(-100.6%)
$484.20M(-3.5%)
Dec 2018
$501.55M(+343.9%)
$274.17M(>+9900.0%)
$501.55M(+120.6%)
Sep 2018
-
-$1.73M(-100.8%)
$227.37M(-0.8%)
Jun 2018
-
$213.41M(+1259.9%)
$229.10M(+1359.9%)
Mar 2018
-
$15.69M
$15.69M
Dec 2017
$112.98M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual cash from financing year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly cash from financing year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM cash from financing year-on-year change?

What is BridgeBio Pharma, Inc. annual cash from financing?

The current annual cash from financing of BBIO is $748.46M

What is the all-time high annual cash from financing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual cash from financing is $748.46M

What is BridgeBio Pharma, Inc. annual cash from financing year-on-year change?

Over the past year, BBIO annual cash from financing has changed by +$296.92M (+65.76%)

What is BridgeBio Pharma, Inc. quarterly cash from financing?

The current quarterly cash from financing of BBIO is $302.04M

What is the all-time high quarterly cash from financing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly cash from financing is $547.91M

What is BridgeBio Pharma, Inc. quarterly cash from financing year-on-year change?

Over the past year, BBIO quarterly cash from financing has changed by +$307.77M (+5372.14%)

What is BridgeBio Pharma, Inc. TTM cash from financing?

The current TTM cash from financing of BBIO is $837.01M

What is the all-time high TTM cash from financing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM cash from financing is $850.29M

What is BridgeBio Pharma, Inc. TTM cash from financing year-on-year change?

Over the past year, BBIO TTM cash from financing has changed by +$260.67M (+45.23%)
On this page